A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled corticosteroids (ICS) and at least one additional asthma controller medication with or without oral corticosteroids.
Epistemonikos ID: 723b99371d0ced379bfd05a52c53aa4745909f01
First added on: May 15, 2024